DE60335922D1 - Verfahren zur Unterscheidung von Metaplasien von neoplastischen oder präneoplastischen Läsionen - Google Patents
Verfahren zur Unterscheidung von Metaplasien von neoplastischen oder präneoplastischen LäsionenInfo
- Publication number
- DE60335922D1 DE60335922D1 DE60335922T DE60335922T DE60335922D1 DE 60335922 D1 DE60335922 D1 DE 60335922D1 DE 60335922 T DE60335922 T DE 60335922T DE 60335922 T DE60335922 T DE 60335922T DE 60335922 D1 DE60335922 D1 DE 60335922D1
- Authority
- DE
- Germany
- Prior art keywords
- neoplastic
- hpv
- metaplasia
- distinguishing
- lesions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/708—Specific hybridization probes for papilloma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57411—Specifically defined cancers of cervix
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Geophysics And Detection Of Objects (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Paper (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20020007954 EP1369694A1 (de) | 2002-04-09 | 2002-04-09 | Verfahren zur Unterscheidung zwischen Metaplasien und neoplastischen oder präneoplastischen Läsionen |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60335922D1 true DE60335922D1 (de) | 2011-03-10 |
Family
ID=29433069
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2003618415 Expired - Lifetime DE60318415T2 (de) | 2002-04-09 | 2003-04-08 | Verfahren zur unterscheidung von metaplasien von neoplastischen oder präneoplastischen läsionen |
DE60335922T Expired - Lifetime DE60335922D1 (de) | 2002-04-09 | 2003-04-08 | Verfahren zur Unterscheidung von Metaplasien von neoplastischen oder präneoplastischen Läsionen |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2003618415 Expired - Lifetime DE60318415T2 (de) | 2002-04-09 | 2003-04-08 | Verfahren zur unterscheidung von metaplasien von neoplastischen oder präneoplastischen läsionen |
Country Status (10)
Country | Link |
---|---|
US (6) | US7422859B2 (de) |
EP (3) | EP1369694A1 (de) |
JP (2) | JP4290118B2 (de) |
CN (1) | CN1643378A (de) |
AT (2) | ATE382863T1 (de) |
AU (1) | AU2003274105A1 (de) |
DE (2) | DE60318415T2 (de) |
ES (2) | ES2297209T3 (de) |
MX (1) | MXPA04009584A (de) |
WO (1) | WO2004005927A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1369694A1 (de) | 2002-04-09 | 2003-12-10 | MTM Laboratories AG | Verfahren zur Unterscheidung zwischen Metaplasien und neoplastischen oder präneoplastischen Läsionen |
ES2215957T3 (es) | 2002-08-01 | 2004-10-16 | Mtm Laboratories Ag | Metodo para diagnostico basado en una solucion. |
EP1422526A1 (de) * | 2002-10-28 | 2004-05-26 | MTM Laboratories AG | Verfahren zur verbesserten Diagnose von Dysplasien |
US7972776B2 (en) * | 2005-11-15 | 2011-07-05 | Oncohealth Corporation | Protein chips for HPV detection |
US7732166B2 (en) | 2005-11-15 | 2010-06-08 | Oncohealth Corporation | Detection method for human pappilomavirus (HPV) and its application in cervical cancer |
US8968995B2 (en) * | 2008-11-12 | 2015-03-03 | Oncohealth Corp. | Detection, screening, and diagnosis of HPV-associated cancers |
US8278056B2 (en) * | 2008-06-13 | 2012-10-02 | Oncohealth Corp. | Detection of early stages and late stages HPV infection |
US7838215B2 (en) * | 2007-09-25 | 2010-11-23 | Canvir, Inc. | Advanced cervical cell screening methods |
EP2262911B1 (de) * | 2008-04-17 | 2016-10-12 | QIAGEN Gaithersburg, Inc. | Zusammensetzungen, verfahren und kits mit synthetischen sonden zum nachweis der anwesenheit einer target-nukleinsäure |
WO2010025928A1 (en) * | 2008-09-04 | 2010-03-11 | Mtm Laboratories Ag | Method for prediction of the progression risk of tumors |
EP2427763A4 (de) | 2009-05-07 | 2013-08-21 | Oncohealth Corp | Identifikation eines hohen cin2-grades zur erkennung von früh- und spätstadien sowie zum screening und zur diagnose des menschlichen papillomavirus (hpv) und mit diesem assoziierter krebserkrankungen |
CN102822672B (zh) | 2010-01-08 | 2015-12-09 | 安科健康公司 | 用于诊断和筛选与hpv有关的癌症的高通量细胞基hpv免疫测定 |
JP2014528066A (ja) * | 2011-09-09 | 2014-10-23 | アムジエン・インコーポレーテツド | 癌治療での、EGFrに結合する薬剤を確立することにおける、ヒトパピローマウイルスステータスの使用 |
CN103076453B (zh) * | 2012-12-24 | 2015-04-15 | 何以丰 | P16免疫细胞化学试剂盒及其制备用多肽序列 |
CA2946534A1 (en) * | 2014-04-28 | 2015-11-05 | Arizona Board Of Regents On Behalf Of Arizona State University | Novel methods, bioassays, and biomarkers for hpv-related conditions |
WO2016207414A1 (en) * | 2015-06-25 | 2016-12-29 | Universitaet Des Saarlandes | Improved diagnostic method for hpv-induced cancer and precancerous lesion screening and diagnosis |
EP3921441A1 (de) * | 2019-02-08 | 2021-12-15 | Charité - Universitätsmedizin Berlin | Verfahren zur bestimmung des schweregrades von durch das humane papillomavirus (hpv) induzierter dysplasie |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4281061A (en) * | 1979-07-27 | 1981-07-28 | Syva Company | Double antibody for enhanced sensitivity in immunoassay |
US6316208B1 (en) * | 1994-01-07 | 2001-11-13 | Memorial Sloan-Kettering Cancer Center | Methods for determining isolated p27 protein levels and uses thereof |
US6033847A (en) * | 1995-02-06 | 2000-03-07 | St. Jude Children's Research Hospital | InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof |
US6407062B1 (en) | 1995-09-27 | 2002-06-18 | St. Jude Children's Research Hospital | ARF-P19, a novel regulator of the mammalian cell cycle |
US5723313A (en) | 1995-09-27 | 1998-03-03 | St. Jude Children's Research Hospital | ARF-p19, a novel regulator of the mammalian cell cycle |
US5858683A (en) * | 1996-08-30 | 1999-01-12 | Matritech, Inc. | Methods and compositions for the detection of cervical cancer |
US6303323B1 (en) | 1997-10-21 | 2001-10-16 | Cancer Research Campaign Technology Limited | Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies |
AU751754B2 (en) | 1997-10-21 | 2002-08-29 | Cancer Research Technology Limited | Determination of cellular growth abnormality |
DE19829473C2 (de) * | 1998-07-01 | 2000-08-10 | Magnus Von Knebel Doeberitz Ch | Verfahren zur frühen Diagnose von Carcinomen |
DE19957689A1 (de) | 1999-11-30 | 2001-06-13 | Deutsches Krebsforsch | Proteaseresistenter Tumorsuppressor p14(ARF) |
GB0018140D0 (en) * | 2000-07-24 | 2000-09-13 | Medical Res Council | Screening for abnormalities |
DE10063179A1 (de) * | 2000-12-18 | 2002-06-20 | Bayer Ag | Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern |
BR0306723A (pt) * | 2002-01-07 | 2004-12-21 | Norchip As | Métodos in vitro para selecionar sujeitos humanos para avaliar seu risco de desenvolver carcinoma cervical, e para selecionar sujeitos humanos quanto à presença de hpv integrado ou um genoma de hpv epissÈmico modificado, método in vitro para identificar sujeitos humanos apresentado alterações anormais de células no cervix, e, kit para uso na detecção de transcrições de mrna dos genes l1 e e6 do hpv |
EP1369694A1 (de) | 2002-04-09 | 2003-12-10 | MTM Laboratories AG | Verfahren zur Unterscheidung zwischen Metaplasien und neoplastischen oder präneoplastischen Läsionen |
EP1387173A1 (de) | 2002-07-29 | 2004-02-04 | MTM Laboratories AG | Verfahren zur verbesserten Diagnose von Zervixläsionen basierend auf dem Nachweis von INK4a Genprodukten |
US20050272038A1 (en) | 2002-07-29 | 2005-12-08 | Ruediger Ridder | Compositions and methods for diagnosis and therapy of cancers |
ES2215957T3 (es) | 2002-08-01 | 2004-10-16 | Mtm Laboratories Ag | Metodo para diagnostico basado en una solucion. |
EP1422526A1 (de) | 2002-10-28 | 2004-05-26 | MTM Laboratories AG | Verfahren zur verbesserten Diagnose von Dysplasien |
US7361460B2 (en) | 2003-04-11 | 2008-04-22 | Digene Corporation | Approach to molecular diagnosis of human papillomavirus-related diseases |
WO2010025928A1 (en) | 2008-09-04 | 2010-03-11 | Mtm Laboratories Ag | Method for prediction of the progression risk of tumors |
-
2002
- 2002-04-09 EP EP20020007954 patent/EP1369694A1/de not_active Withdrawn
-
2003
- 2003-04-08 AU AU2003274105A patent/AU2003274105A1/en not_active Abandoned
- 2003-04-08 ES ES03758090T patent/ES2297209T3/es not_active Expired - Lifetime
- 2003-04-08 CN CNA038063328A patent/CN1643378A/zh active Pending
- 2003-04-08 EP EP20030758090 patent/EP1493032B1/de not_active Expired - Lifetime
- 2003-04-08 JP JP2004518777A patent/JP4290118B2/ja not_active Expired - Lifetime
- 2003-04-08 WO PCT/EP2003/050096 patent/WO2004005927A1/en active IP Right Grant
- 2003-04-08 DE DE2003618415 patent/DE60318415T2/de not_active Expired - Lifetime
- 2003-04-08 MX MXPA04009584A patent/MXPA04009584A/es active IP Right Grant
- 2003-04-08 EP EP20070106444 patent/EP1821102B1/de not_active Expired - Lifetime
- 2003-04-08 AT AT03758090T patent/ATE382863T1/de active
- 2003-04-08 DE DE60335922T patent/DE60335922D1/de not_active Expired - Lifetime
- 2003-04-08 ES ES07106444T patent/ES2360342T3/es not_active Expired - Lifetime
- 2003-04-08 AT AT07106444T patent/ATE497169T1/de not_active IP Right Cessation
- 2003-04-08 US US10/511,108 patent/US7422859B2/en not_active Expired - Lifetime
-
2008
- 2008-06-30 US US12/164,934 patent/US8043819B2/en not_active Expired - Fee Related
- 2008-09-22 JP JP2008243422A patent/JP4809408B2/ja not_active Expired - Lifetime
-
2011
- 2011-08-25 US US13/137,547 patent/US8815520B2/en not_active Expired - Lifetime
-
2014
- 2014-07-07 US US14/325,282 patent/US10822660B2/en not_active Expired - Lifetime
-
2017
- 2017-04-05 US US15/479,961 patent/US10246751B2/en not_active Expired - Lifetime
-
2019
- 2019-02-19 US US16/279,900 patent/US11155878B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
MXPA04009584A (es) | 2005-01-11 |
US20090104609A1 (en) | 2009-04-23 |
DE60318415T2 (de) | 2009-01-08 |
JP4809408B2 (ja) | 2011-11-09 |
EP1821102A1 (de) | 2007-08-22 |
US20120052510A1 (en) | 2012-03-01 |
US20050255468A1 (en) | 2005-11-17 |
EP1493032A1 (de) | 2005-01-05 |
AU2003274105A1 (en) | 2004-01-23 |
US10822660B2 (en) | 2020-11-03 |
ATE382863T1 (de) | 2008-01-15 |
US8043819B2 (en) | 2011-10-25 |
US7422859B2 (en) | 2008-09-09 |
CN1643378A (zh) | 2005-07-20 |
US11155878B2 (en) | 2021-10-26 |
EP1493032B1 (de) | 2008-01-02 |
EP1369694A1 (de) | 2003-12-10 |
JP2005523039A (ja) | 2005-08-04 |
US8815520B2 (en) | 2014-08-26 |
ES2297209T3 (es) | 2008-05-01 |
WO2004005927A1 (en) | 2004-01-15 |
JP2009000127A (ja) | 2009-01-08 |
JP4290118B2 (ja) | 2009-07-01 |
US20190177804A1 (en) | 2019-06-13 |
US10246751B2 (en) | 2019-04-02 |
US20140308660A1 (en) | 2014-10-16 |
US20170268068A1 (en) | 2017-09-21 |
ES2360342T3 (es) | 2011-06-03 |
DE60318415D1 (de) | 2008-02-14 |
EP1821102B1 (de) | 2011-01-26 |
ATE497169T1 (de) | 2011-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60335922D1 (de) | Verfahren zur Unterscheidung von Metaplasien von neoplastischen oder präneoplastischen Läsionen | |
RU2008142996A (ru) | Магниторезистивный датчик в качестве датчика температуры | |
ATE525482T1 (de) | Nanoreporter und verfahren zu deren herstellung und verwendung | |
ATE548467T1 (de) | Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände | |
ATE538213T1 (de) | Vorrichtung und verfahren zum identifizieren genomischer dna von organismen | |
DE602005015299D1 (de) | Verfahren, chip, vorrichtung und integriertes system zum nachweis biologischer partikel | |
DE602006019111D1 (de) | Verfahren zur isolierung von analyten aus einer probe | |
DE69816286D1 (de) | Verfahren zur Erkennung von Nukleinsäuremethylierungen durch AFLP | |
EP2145180A4 (de) | Vergleichende sequenzanalyseverfahren und -systeme | |
ATE516370T1 (de) | Verfahren zur erfassung von krebszellen unter verwendung eines virus | |
DE602004021185D1 (de) | Auf bio-barcodes beruhender nachweis von zielanalyten | |
DE602004009716D1 (de) | Verwendung von transthyretin als biomarker zum nachweis von kolorektalen adenomen; verfahren und nachweis-system | |
WO2007030324A3 (en) | Sample identification system having plural readers | |
ATE452990T1 (de) | Verfahren zur zählung und identifikation von mikroorganismen | |
PL1668152T3 (pl) | Identyfikacja sygnatury ekspresji genów ERBB2 w rakach sutka | |
DE59712894D1 (de) | Verfahren zum nachweis klinisch relevanter veränderungen der dns-sequenz des ki-ras-onkogens, seine verwendung und testkit zur früherkennung von tumoren | |
ATE431428T1 (de) | Ein verfahren zur analyse von polynukleotiden | |
ATE335854T1 (de) | Verfahren zur identifizierung von umweltkontaminationen durch detektion von enteroviren | |
ATE394675T1 (de) | Verfahren zum nachweis von brustkrebs | |
WO2017001597A1 (en) | Method for determining a size of biomolecules | |
DE60121547D1 (de) | Electrochemisches verfahren zum nachweis von nukleinsäuren | |
DE602004019180D1 (de) | Methode zur Identifizierung von unbekannten Proteinen mittels zwei-dimensionaler Auftrennung und Verwendung von Markern | |
ATE283484T1 (de) | Verfahren zur verbesserten diagnose von dysplasien | |
GB0304832D0 (en) | Assay method | |
ATE376668T1 (de) | Verfahren zum nachweis der auswirkungen von störeffekten auf messdaten |